Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus.
- Published in:
- Antioxidants, 2023, v. 12, n. 3, p. 625, doi. 10.3390/antiox12030625
- By:
- Publication type:
- Article
Works by Raimondi, Vittoria
Results: 9
1
2
Oncogenic pathways and the electron transport chain: a dangeROS liaison.
- Published in:
- 2020
- By:
- Publication type:
- journal article
3
A basic introduction to single particles cryo-electron microscopy.
- Published in:
- AIMS Biophysics, 2022, v. 9, n. 1, p. 5, doi. 10.3934/biophy.2022002
- By:
- Publication type:
- Article
4
2-Hydroxyglutarate in Acute Myeloid Leukemia: A Journey from Pathogenesis to Therapies.
- Published in:
- Biomedicines, 2022, v. 10, n. 6, p. 1359, doi. 10.3390/biomedicines10061359
- By:
- Publication type:
- Article
5
Mitochondrial Proteins Coded by Human Tumor Viruses.
- Published in:
- Frontiers in Microbiology, 2018, p. 1, doi. 10.3389/fmicb.2018.00081
- By:
- Publication type:
- Article
6
Nanoparticles as Tools to Target Redox Homeostasis in Cancer Cells.
- Published in:
- Antioxidants, 2020, v. 9, n. 3, p. 211, doi. 10.3390/antiox9030211
- By:
- Publication type:
- Article
7
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5874, doi. 10.3390/cancers13235874
- By:
- Publication type:
- Article
8
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3358, doi. 10.3390/cancers13133358
- By:
- Publication type:
- Article
9
MiR-150 in HTLV-1 infection and T-cell transformation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.974088
- By:
- Publication type:
- Article